Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes

View source ↗

Summary

An NCI protocol to identify sporadic chordoma patients for future studies of cancer-susceptibility genes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Genes, Sporadic Chordoma | Status: ACTIVE_NOT_RECRUITING